Recherche - Université de Picardie Jules Verne Accéder directement au contenu

Filtrer vos résultats

5 Résultats
Structure : Identifiant HAL de la structure : 525555

Effectiveness and safety of ustekinumab induction therapy in ulcerative colitis: A GETAID real-world cohort study

A. Amiot , A. Vered , J. Filippi , G. Cadiot , D. Laharie , et al.
Journal of Crohn's and Colitis, 2020, 14 (1), pp.S579
Article dans une revue hal-03552084v1

Prognosis and chemosensitivity of non-V600E BRAF mutations in metastatic colorectal carcinoma (mCRC): An AGEO French multicenter retrospective cohort.

Aline Derosiere , Vincent Nicolai , David Malka , Astrid Pozet , Julien Lazartigues , et al.
Journal of Clinical Oncology, 2019, 37 (15, S), ⟨10.1200/JCO.2019.37.15\_suppl.3575⟩
Article dans une revue hal-03606012v1

Acceptability of treatment regimen in inflammatory bowel disease: Results from a prospective nationwide study (ACCEPT2)

A. Buisson , Mathurin Fumery , M. Serrero , L. Orsat , S. Nancey , et al.
2020, pp.S337-S338
Autre publication scientifique hal-03551532v1

Validation of IBD-disk for the assessment of daily-life burden of patients with inflammatory bowel disease

S. Tadbiri , M. Nachury , Y. Bouhnik , M. Serrero , F. Jerome , et al.
Journal of Crohn's and Colitis, 2020, 14 (1), pp.S272
Article dans une revue hal-03551538v1

Which second-line biologic after anti-TNF failure during Crohn's disease: Ustekinumab or vedolizumab, a multicentre retrospective study

C. Rayer , X. Roblin , D. Laharie , Benoît Caron , M. Flamant , et al.
Journal of Crohn's and Colitis, 2020, 14 (1), pp.S547. ⟨10.1093/ecco-jcc/jjz203.793⟩
Article dans une revue hal-03551537v1